Sertraline-13C-15N-d3 CAS CATO-C4X-13449
| CAS No. | CATO-C4X-13449 |
| Molecular Formula | C16[13C]H14D3Cl2[15N] |
| Molecular Weight | 311.23 g/mol |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Sertraline-13C-15N-d3 (C16[13C]H14D3Cl2[15N]) contains deuterium isotope labeling, a nitrogen-containing heterocyclic scaffold, a nitrile group, chlorine substitution. Halogen substitution raises its density and boiling point, its high carbon-to-hydrogen ratio confers good lipid solubility; these physicochemical properties determine the optimal preparation and storage of its standard solutions. Halogen substitution (F/Cl/Br/I) produces a distinctive isotope pattern in mass spectrometry, a valuable aid for qualitative confirmation.
Sertraline-13C-15N-d3 (CAS CATO-C4X-13449) is a high-purity analytical reference standard with the molecular formula C16[13C]H14D3Cl2[15N] and a molecular weight of 311.23 g/mol.
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C16[13C]H14D3Cl2[15N] |
| Molecular Weight | 311.23 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 10.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 1 |
Related Sertraline Standards
- Sertraline Impurity 70 (CAS CATO-C4X-134470)
- Sertraline Impurity C49 (CAS 140631-53-4)
- Sertraline EP Impurity G (CAS 79617-98-4)
- Sertraline Impurity 53 (CAS 2184053-08-3)
- Sertraline (CAS 79617-96-2)
- Sertraline EP Impurity A (CAS 79836-45-6)
- Sertraline oxime Impurity (CAS 152642-35-8)
- Sertraline Impurity 64 (CAS 79560-20-6)
Recommended Standards
- 4-{2-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]ethyl}morpholine 4-{2-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethyl}morpholine 864754-18-7 (CAS 864754-18-7)
- 4-Bromo-2,6-dimethyl-N-((2-methylthiazol-4-yl)methyl)aniline (CAS 1184576-42-8)
- 3-Hydroxy-2,3-dimethylbutan-2-yl hydrogen (4-(thiophen-3-yl)thiazol-5-yl)boronate (CAS 2223039-38-9)
- 5-(4-Bromophenyl)-2-(isopropylthio)-1-methyl-1H-imidazole (CAS 1206989-96-9)
- 2,8-Dibromo-6,12-dihydroindeno[1,2-b]fluorene (CAS 848982-57-0)
- 2-Methyl-4-(4-(trifluoromethyl)benzyl)-4H-thieno[3,2-b]pyrrole-3-carboxylic acid (CAS 1207954-47-9)
- 1-(3-Isopropyl-1-propyl-5-vinyl-1H-pyrazol-4-yl)-2-methylpropan-1-one (CAS 1956370-11-8)
- 3-methanesulfonyl-1H-indole (CAS 582321-06-0)
- Phenol, 2,3-dimethyl-4-(phenylmethoxy)- (CAS 854663-38-0)
- 2-Cyclopropyl-1H-benzo[d]imidazole-5-carboxylic acid (CAS 1082847-74-2)
- Bromodimethylsulfonium bromide (CAS 50450-21-0)
- 3-(2-fluoro-3-methylphenyl)propanal (CAS 955403-65-3)
- 4-Bromo-1H-pyrrolo[2,3-b]pyridin-5-ol (CAS 1190318-15-0)
- Semaglutide impurity 85 (CAS CATO-C4X-222685)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com